Kenneth J. Pienta

Dr. Kenneth J. Pienta is the Donald S. Coffey Professor of Urology and Director of Research at the Brady Urological Institute of the Johns Hopkins University School of Medicine. He is also a Professor in the Departments of Oncology and Pharmacology and Molecular Sciences and serves as a faculty member in the Cellular and Molecular Medicine and Pathobiology Programs at the Johns Hopkins School of Medicine. He is also a Professor of Chemical and Biomolecular Engineering in the Whiting School of Engineering at Johns Hopkins University. Ken is a two-time American Cancer Society Clinical Research Professor Award recipient. Ken has a proven, peer-reviewed track record in organizing and administering a translational research program that successfully incorporates bench research, agent development, and clinical application. He has international expertise in the development of novel therapeutic programs for prostate cancer. He is the author of more than 400 peer-reviewed articles, and been the principal investigator on numerous local and national clinical trials. Ken is the holder of multiple patents, is co-founder of OncoFusion where he serves on the Scientific Advisory Board and he has served as a Scientifc Advisory Board member or consultant to biotechnology companies including Curis, Amgen, J&J, Millenium, Gtx, Myriad Genetic Labs and Compendia.